Atnaujinkite slapukų nuostatas

El. knyga: White cells and platelets in blood transfusion: Proceedings of the Eleventh Annual Symposium on Blood Transfusion, Groningen 1986, organized by the Red Cross Blood Bank Groningen-Drenthe

Edited by , Edited by , Edited by
Kitos knygos pagal šią temą:
White cells and platelets in blood transfusion: Proceedings of the Eleventh Annual Symposium on Blood Transfusion, Groningen 1986, organized by the Red Cross Blood Bank Groningen-DrentheDidesnis paveikslėlis
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

As a clinical discipline blood transfusion encompasses enormous vista, vary­ ing from biotechnology to molecular biology, from plasma products, cell biology and growth factors to interleukines. Growth of knowledge in this field has been rapid, and expertise is now required to be mastered and renewed in translating these ideas for patient care. Various types of cells could be harvested - progenitor stem cells derived from bone marrow or from circulating blood as a source for transplants; in the hemostatic armoury platelets could be used prophylactically; granulocytes and mononuclear cells are available for treatment of infections or immune modulations. However, their therapeutic use carries potential complications including graft versus host disease and CMV-infection. Prevention of such complications by irradiation and by removal of immunocompetent leukocytes are important issues. Thus, production of such therapeutic materials ought to address the issues at the earliest, to eliminate those problems while adhering to the con­ cept of high quality; the impact of storing platelets for longer periods by using improved plastic containers or storing almost indefinitely in frozen state should be explored. Rapid progress in cell culture techniques and bio­ technology have enriched the transfusion medicine armoury with lympho­ kines, interferons and cell colony growth factors which have great potentials for enhancement of basic knowledge as well as considerable therapeutic applications in patients.

Proceedings of the Eleventh Annual Symposium on Blood Transfusion, Groningen 1986, organized by the Red Cross Blood Bank Groningen-Drenthe

Daugiau informacijos

Springer Book Archives
I. Principles and functional aspects.- The human MHC (HLA) and immediate
relevance in transfusion Practice.- Alloimmunization against platelets and
granulocytes.- Leukocytes in transfusion medicine an overview of functions
and clinical implications.- Platelet functions and platelet transfusion.-
Discussion.- II. Clinical Aspects.- A.Presence of cells.- Platelet
transfusion.- Prospective selection of compatible platelet donors for
alloimmunized patients by an ELISA platelet cross-match only.- White blood
cell transfusions in the immuno-compromised patients.- Immunization with
antigen-bound antibody: an experimental approach to prevention of
sensitization to allogeneic blood cells.- Autologous bone marrow
transplantation in acute myeloblastic leukemia (AML): in vitro studies to
detect minimal disease in remission marrow.- Autologous bone marrow
transplantation in solid malignancies.- Discussion.- Clinical use of
leukocyte poor red cell concentrates.- Management and prevention of
cytomegalovirus infection.- Graft-versus-Host disease and the role of blood
product irradiation.- Perspectives for lymphokine therapy: from genetic
engineering to immunologic engineering.- Discussion.- III. Production
aspects.- Practical aspects of platelet concentrate production and storage.-
Surge plateletapheresis.- Platelets and propylene glycol: an approach to
freezing platelets in the presence of a new cryoprotectant.- Bacterial
contamination in platelets stored at ambient temperature.- Preparation of
leukocyte-poor blood.- Use of hemapheresis-derived hemopoietic stem cells for
transplantation in malignant lymphohemopoietic disorders.- Purging of bone
marrow.- Discussion.- IV. Laboratory aspects.- HLA-matching and crossmatching
in platelet transfusion.- Cell culture and immune functiontests.- Platelet
antibody detection.- Decreased fluidity of human platelet membranes after
interaction with an anti PLA1 antibody.- Role of white cells in reagents for
AIDS.- Discussion.
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97814613208902e.html
Raktažodžiai: